Robert Langer

Director at Syntis BIO.

Raised on Syntis BIO filings

$31.3M

of $35.5M offered across 2 Form D filings

Form D filings: 2
Teammates: 6
Last filing: Jul 2, 2025

Company

Biotech · Boston, MA

Oral pill that mimics gastric bypass for weight loss

Oral pill that mimics gastric bypass for weight loss

Investors: 9
Founded: 2022
Still open: $4.2M

Investors: 9
Sector: Biotech
Founded: 2022
HQ: Boston, MA

Syntis BIO filings

Syntis BIO Form D filings
Filed	Security	Sold of offered	Filing
Jul 2, 2025	Equity	$25M/ $26.5M	Form D
Jan 27, 2025	Equity	$6.3M/ $9M	Form D

EquityFiled Jul 2, 2025Form D
$25M/ $26.5M
EquityFiled Jan 27, 2025Form D
$6.3M/ $9M

Works with

Also named on Syntis BIO filings

Rahul DhandaChief Executive Officer, Form D signerForm D signer Michael NannizziDirector Carlo Giovanni TraversoDirector Teymour Boutros-GhaliDirector Chenny ZhangDirector Martin MadausDirector